Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Banco Santander S.A. ADS (NY: SAN)
6.936 USD  -0.114 (-1.61%)
Streaming Delayed Price  /  Updated: 11:01 AM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Banco Santander S.A. ADS
 
< Previous 1 2 3 4 5 6 7 8 9
...
77 78 Next >
Special Offer for Shareholders of JNJ, KO, CLNT and SAN
Today 5:00 EDT
from Marketwired News Releases
Pfizer takes its shot at a vaccine for evasive superbug
Today 1:20 EDT
Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year... Read More
from FOX News
UPDATE 2-Merck's insomnia drug moves a step closer to U.S. approval
May 22, 2013
* FDA panel says suvorexant safe, effective at lower doses Read More
category companyNews
from Reuters: Company News
UPDATE 1-FDA panel says Merck's sleep drug safe, effective at lower dose
May 22, 2013
WASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug was safe and effective at the lower of two doses studied, a panel of medical experts said on Wednesday, increasing the chance it... Read More
category companyNews
from Reuters: Company News
FDA panel: Merck's insomnia drug effective, safe at low doses
May 22, 2013
WASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug is safe and effective at the lower of two doses studied but not at the higher, a panel of medical experts said on Wednesday. Read More
category companyNews
from Reuters: Company News
Thrifty Merrimack developing new cancer drugs at lower cost
May 22, 2013
NEW YORK, May 22 (Reuters) - Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipeline of experimental cancer treatments that it aims to deliver at a fraction... Read More
category companyNews
from Reuters: Company News
UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changer
May 21, 2013
May 21 (Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for... Read More
category companyNews
from Reuters: Company News
Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global Consolidation
May 21, 2013
from Business Wire News Releases
Regeneron settles all pending litigation with Roche's Genentech
May 20, 2013
May 20 (Reuters) - Regeneron Pharmaceuticals Inc said it settled all pending litigation with Roche Holding AG's unit Genentech on the company's eye drug, Eylea, and cancer drug, Zaltrap. Read More
category companyNews
from Reuters: Company News
UPDATE 3-FDA staff says Merck's sleep drug effective, questions dosage
May 20, 2013
* Reviewers say lower doses of suvorexant safer than high * Cite risk of next-day sedation, suicidal thinking * Merck shares fall 1 percent in midday trading By Toni Clarke WASHINGTON, May 20 (Reuters)... Read More
category companyNews
from Reuters: Company News
FDA staff say Merck's sleep drug effective, question dose levels
May 20, 2013
May 20 (Reuters) - *FDA STAFF REVIEWERS SAY CLINICAL TRIALS OF MERCK'S SLEEP DRUG SUVOREXANT "OVERALL, ESTABLISH EFFECTIVENESS." *FDA STAFF REVIEWERS SAY SUVOREXANT SEEMS TO BE ASSOCIATED WITH EVENTS... Read More
category companyNews
from Reuters: Company News
Highlights on Options Trading for Banco Santander-Chile (SAN)
May 17, 2013
NEW YORK (AVAFIN) -- Banco Santander-Chile options set a new 90-day record for the ... Read More
from AVAFIN
Top 4 Large-Cap Stocks In The Foreign Money Center Banks Industry With The Lowest PEG Ratio
May 16, 2013
Below are the top large-cap foreign money center banks stocks on the NYSE and the NASDAQ in terms of PEG ratio. Lloyds Banking Group plc (NYSE: LYG ) has a PEG ratio of 0.22. Lloyds Banking had $415.37... Read More
category Foreign Money Center Banks Industry , Benzinga , BCS , and 8 more.
from Latest Articles from Benzinga.com
Cash Dividend On The Way From Banco Santander SA's Floating Rate Non-Cumulative Series 6 Guaranteed Preferred Securities
May 15, 2013
On 5/17/13, Banco Santander SA's Floating Rate Non-Cumulative Series 6 Guaranteed Preferred Securities (SAN. RB) will trade ex-dividend, for its quarterly dividend of $0.25, payable on 6/5/13. Read More
category Stocks
from Market News Video
JPMorgan, Portugal in talks to resolve swaps tussle-source
May 15, 2013
The Portuguese government and JP Morgan Chase & Co are attempting to resolve a tussle over potentially costly derivative contracts sold by the U.S. investment bank to state-owned companies. Read More
from FOX News
Perfect Trade Setups, How to Play DIS, SAN, FLEX and CBS
May 15, 2013
from Marketwired News Releases
FDA approves labels with lower doses for zolpidem sleep drugs
May 14, 2013
May 14 (Reuters) - The U.S. Food and Drug Administration approved label changes incorporating lower dosages for sleep medications containing zolpidem, a drug that can continue to affect patients'... Read More
category companyNews
from Reuters: Company News
New Market Report: Sanofi (SAN) - Product Pipeline Analysis, 2013 Update
May 14, 2013
from PRBuzz Press Release Distribution
A taste for defensives sours prospects for European stocks
May 14, 2013
LONDON, May 14 (Reuters) - Defensive stocks such as healthcare companies, which often bring up the rear when markets rise, have led the gainers in 2013 as European bourses hit their highest in years,... Read More
category companyNews
from Reuters: Company News
UPDATE 1-Merck KGaA steps up cost savings, boosting profit
May 14, 2013
FRANKFURT, May 14 (Reuters) - German drugs and chemicals maker Merck KGaA on Tuesday said it would meet its 2014 sales and earnings goals already this year as it unveiled a sharp jump in first-quarter... Read More
category companyNews
from Reuters: Company News
SAN Named Top 10 Financial at Dividend Channel With 10.44% Yield
May 09, 2013
Banco Santander SA (SAN) has been named as a Top 10 dividend-paying financial stock, according to Dividend Channel, which published its most recent ''DividendRank'' report. The report noted that among... Read More
category Dividends
from Dividend Channel
Cautious Optimism Is the Latest News From Europe
May 09, 2013
 Read More
category NYSE:BBVA , NYSE:SAN , Market Insight: Financial Articles
from InvestorPlace - Latest Headlines
U.S. spending on medicines fell for first time in 2012
May 08, 2013
May 9 (Reuters) - Patent expirations on big-name drugs such as Lipitor and Plavix has resulted in modestly less spending on medicines in the United States for the first time in at least 55 years,... Read More
category companyNews
from Reuters: Company News
Closing Bell for Monday on Wall Street: Markets Mixed at Open, Mixed at Close
May 06, 2013
DailyFinance.com : U.S. equity markets opened mixed this morning after most of the day's economic data was delivered in Europe. Eurozone PMI rose slightly more than expected (more coverage here) and... Read More
category apo , yrcw , san , and 18 more.
from DailyFinance.com
Europe stocks flat as London takes a break
May 06, 2013
Europe stock markets struggle for direction on Monday, with volumes hampered by a lack of trading in London. Retail sales data for Europe will be among the few focal points, while shares of Linde AG... Read More
category XX:IBEX , Retail , DX:DAX , and 17 more.
from MarketWatch
Citi Downgrades Banco Santander (SAN) to Sell
May 03, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8304134 for the full story. Read More
from StreetInsider.com News Articles
Lilly broadens diabetes offer with eye on bigger slice of booming market
May 03, 2013
* Head of diabetes says eyeing broadest portfolio in industry Read More
category companyNews
from Reuters: Company News
Regeneron raises 2013 Eylea sales view, profit beats Street
May 03, 2013
May 3 (Reuters) - Regeneron Pharmaceuticals Inc's first-quarter results beat analysts' estimates for the seventh straight quarter as the sales of its eye drug Eylea continued to gather pace, and the... Read More
category companyNews
from Reuters: Company News
Big drugmakers think small with nanomedicine deals
May 03, 2013
* Early-stage research but scientists see momentum building Read More
category companyNews
from Reuters: Company News
ADR REPORT-ECB rate cut, jobless claims data lift ADRs
May 02, 2013
NEW YORK, May 2 (Reuters) - U.S.-listed shares of foreign companies rose on Thursday, buoyed by an interest rate cut from the European Central Bank and a sharp decline in U.S. weekly unemployment... Read More
category companyNews
from Reuters: Company News
< Previous 1 2 3 4 5 6 7 8 9
...
77 78 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here